This compound is a modified uridine phosphoramidite designed for automated oligonucleotide synthesis. It features a dimethoxytrityl (DMTr) protecting group, a 2'-O-docosyl (C22) modification, and a 3'-cyanoethyl phosphoramidite moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2923115-86-8
2'-O-Hexadecyl-U-CE-Phosphoramidite
pharmaceutical intermediate
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-propyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
research compound
Methyl 16-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-2-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl]oxyhexadecanoate
pharmaceutical intermediate
2'-propargyl U amidite
pharmaceutical intermediate
5'(E)-VP-2 inverted exclamation mark -F-U-CE-Phoshoramidite
pharmaceutical intermediate
3-Desethyl-3-(2-aminoethyl) aminoethoxy Amlodipine
pharmaceutical intermediate
2-Fluorophenylhydrazine hydrochloride
pharmaceutical intermediate
5-Bromo-6-chloronicotinic acid
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-docosoxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
UVVBAOHROLTNIE-PGNDMMQRSA-N
CCCCCCCCCCCCCCCCCCCCCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N
—